FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to infectious diseases, nephrology and dermatovenereology. For method purposes urine is tested for 1-1-benzodioxy-5-ol, 2-propanamide, 1-4-ditosile-2,3- isopropyl-b-treytole, nitrobenzen, 4-4- acetamide-2,2,6,6-tatramethyl-oxyl- piperydine, N-aminooxymethyl-acetamide, 2-methyl-5-1-methyl-ethyl-phenole and 4- 4-1-methylethylbutylphenol by gas- chromatography and mass-spectrography. If amount is 0.03-0.05 mmole/l; 0.07-0.09 mmole/l; 0.09-0.11 mmole/l; 0.04-0.06 mmole/l; 0.05-0.07 mmole/l; 0.07-0.10 mmole/l; 0.11-0.13 mmole/l and 0.13-0.16 mmole/l respectively kidney infectious pathology is diagnosed. Invention provides non-invasive and informative detection of molecular markers of kidney infectious pathology caused by syphilis.
EFFECT: non-invasive diagnostics of kidney infectious pathology caused by syphilis.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING ALTERATIONS OF CENTRAL NERVOUS SYSTEM AT SYPHILIS | 2006 |
|
RU2315303C1 |
| DIAGNOSTIC TECHNIQUE FOR INFECTIVE RENAL PATHOLOGY | 2013 |
|
RU2539386C1 |
| POLYCYCLIC ANTAGONISTS OF TLR7/8 AND THEIR USE IN TREATMENT OF IMMUNE DISORDERS | 2016 |
|
RU2783748C2 |
| SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
| PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
| SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
| PYRIDINES, PYRIMIDINES AND PYRAZINES AS BRUTON'S TYROSINE KINASE INHIBITORS AND USE THEREOF | 2014 |
|
RU2712220C2 |
| GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811403C2 |
| GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811408C2 |
| ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS | 2019 |
|
RU2811969C2 |
